Found: 7
Select item for more details and to access through your institution.
Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 3, p. 505, doi. 10.1007/s00432-010-0914-8
- By:
- Publication type:
- Article
Aspirin Minimized the Pro-Metastasis Effect of Sorafenib and Improved Survival by Up-Regulating <i>HTATIP2</i> in Hepatocellular Carcinoma
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0065023
- By:
- Publication type:
- Article
The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular Carcinoma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0059771
- By:
- Publication type:
- Article
Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055945
- By:
- Publication type:
- Article
A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 5, p. 861, doi. 10.1007/s10637-010-9435-1
- By:
- Publication type:
- Article
MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression.
- Published in:
- Carcinogenesis, 2013, v. 34, n. 9, p. 2071, doi. 10.1093/carcin/bgt160
- By:
- Publication type:
- Article
Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 439, doi. 10.1186/1471-2407-12-439
- By:
- Publication type:
- Article